Lee's Pharmaceutical Holdings Limited (FRA:L1PA)

Germany · Delayed Price · Currency is EUR

0.1520

0.00 (0.00%)

Last updated: Feb 20, 2026, 8:00 AM CET

Revenue by Segment

Financials in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Licensed-In Products	553.24M	467.28M	733.34M	749.14M	677.95M
Licensed-In Products Growth	18.40%	-36.28%	-2.11%	10.50%	-0.78%
Proprietary and Generic Products	846.73M	585.76M	499.81M	517.02M	538.77M
Proprietary and Generic Products Growth	44.55%	17.20%	-3.33%	-4.04%	0.59%
Total	1.40B	1.05B	1.23B	1.27B	1.22B
Total Growth	32.95%	-14.61%	-2.61%	4.06%	-0.18%

Revenue by Geography

Financials in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
The People's Republic of China (The PRC)	1.40B	1.05B	1.23B	1.27B	1.22B
The People's Republic of China (The PRC) Growth	32.95%	-14.61%	-2.61%	4.06%	-0.18%
Total	1.40B	1.05B	1.23B	1.27B	1.22B
Total Growth	32.95%	-14.61%	-2.61%	4.06%	-0.18%

Source: S&P Global Market Intelligence.